Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice.

[1]  T. Mor,et al.  Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate. , 2006, Vaccine.

[2]  B. Genton,et al.  Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine. , 2006, Vaccine.

[3]  Zhong Huang,et al.  Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. , 2006, Vaccine.

[4]  Zhong Huang,et al.  Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. , 2005, Vaccine.

[5]  N. Natarajan,et al.  Immunogenicity in humans of an edible vaccine for hepatitis B. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Lei Jiang,et al.  Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. , 2005, The Journal of general virology.

[7]  H. S. Kim,et al.  Expression of the hepatitis B surface S and preS2 antigens in tubers of Solanum tuberosum , 2004, Plant Cell Reports.

[8]  Leslie L. Domier,et al.  Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response , 2000, Transgenic Research.

[9]  H. Davis,et al.  DNA-based immunization against hepatitis B virus , 2004, Springer Seminars in Immunopathology.

[10]  M. Shuler,et al.  Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies. , 2003, Vaccine.

[11]  Wei Zhou,et al.  Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA. , 2003, Virology.

[12]  N. Xia,et al.  Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg. , 2003, World journal of gastroenterology.

[13]  F. Zoulim,et al.  Perspectives on therapy of hepatitis B. , 2003, Journal of hepatology.

[14]  I. Raskin,et al.  Plants and human health in the twenty-first century. , 2002, Trends in biotechnology.

[15]  P. Payette,et al.  Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. , 2002, FEMS immunology and medical microbiology.

[16]  C. Arntzen,et al.  Oral immunization with hepatitis B surface antigen expressed in transgenic plants , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Cordell.  Biodiversity and drug discovery--a symbiotic relationship. , 2000, Phytochemistry.

[18]  C. Arntzen,et al.  Production of hepatitis B surface antigen in transgenic plants for oral immunization , 2000, Nature Biotechnology.

[19]  D J Newman,et al.  The influence of natural products upon drug discovery. , 2000, Natural product reports.

[20]  M. Shuler,et al.  Process Options in Hepatitis B Surface Antigen Extraction from Transgenic Potato , 2000, Biotechnology progress.

[21]  W. Jilg.  Novel hepatitis B vaccines. , 1998, Vaccine.

[22]  M. Levine,et al.  Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato , 1998, Nature Medicine.

[23]  P. Dalal,et al.  High occurrence of HBV among STD clinic attenders in Bombay, India , 1998, International journal of STD & AIDS.

[24]  C. Ryu,et al.  Generation and characterization of a humanized antibody with specificity for preS2 surface antigen of hepatitis B virus. , 1996, Hybridoma.

[25]  Y. Kim,et al.  Production of hepatitis B virus preS polypeptide in Escherichia coli by mutation of the 5'-end coding sequence and its purification and characterization. , 1996, Gene.

[26]  P. Lyons,et al.  Immunogenicity of transgenic plant-derived hepatitis B surface antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Trépo,et al.  Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid , 1993, Journal of medical virology.

[28]  R. Purcell,et al.  Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. M. Lam,et al.  Expression of hepatitis B surface antigen in transgenic plants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Kim,et al.  Cloning and characterization of cDNAs coding for heavy and light chains of a monoclonal antibody specific for pre-S2 antigen of hepatitis B virus. , 1992, Gene.

[31]  H. Miyazaki,et al.  Mutations within the S Gene of Hepatitis B Virus Transmitted from Mothers to Babies Immunized with Hepatitis B Immune Globulin and Vaccine , 1992, Pediatric Research.

[32]  A. McBean,et al.  Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. , 1990, The Journal of infectious diseases.

[33]  A. Neurath,et al.  Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. , 1989, Vaccine.

[34]  P. Pontisso,et al.  Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region , 1989, Journal of virology.

[35]  D. Peterson.  The structure of hepatitis B surface antigen and its antigenic sites , 1987, BioEssays : news and reviews in molecular, cellular and developmental biology.

[36]  S. Mishiro,et al.  A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Kent,et al.  Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein. , 1986, Molecular immunology.

[38]  W. Gerlich,et al.  Large surface proteins of hepatitis B virus containing the pre-s sequence , 1984, Journal of virology.